NCT06845787

Brief Summary

Rationale: Admission into a pediatric intensive care unit (PICU) can be a highly stressful experience, with many children demonstrating posttraumatic stress symptoms. Most patients require titration of pain and sedation medications to facilitate care, but there is increasing concern of the impact of these medications on the developing brain and increased health risks, including drug withdrawal syndrome, delirium, and impaired circadian rhythm. One potential nonpharmacologic approach to decreasing stress and improving comfort is live-performed music therapy. Among mechanically ventilated adults, music therapy decreased physiologic and psychologic responses to stress (e.g., vital signs, self-reported anxiety) and sedative use. The use of live-performed music may be more advantageous than recorded music with a critically ill population because a music therapist is trained to manipulate musical elements to facilitate the desired outcomes and can respond immediately and adequately in response to the patient's reactions. Objective: To study the effects of live-music therapy on patient comfort, and on patient and parental stress levels and parent-child interaction, use of sedato-analgesic drugs, on haemodynamics and respiration and on the occurrence of patient-ventilator synchrony. Study design: Randomised, non-blinded pilot study Study population: Children \< 5 years old and with expected mechanical ventilatory support for at least 48 hours after inclusion. Intervention: Live-music or care-as-usual. Main study parameters/endpoints: The main study endpoint is patient comfort measured with the Dutch Version of the COMFORT Behaviour (COMFORT-B) scale. Secondary endpoints include parental stress levels, changes in hemodynamic variables (heart rate, blood pressure), changes in respiratory parameters (respiration rate, oxygen saturation, pressure-rate product, pressure-time product), daily cumulative dose of benzodiazepines, alpha-2-agonists and opioids, on-demand boluses of benzodiazepines and opioids, number of asynchronous breaths, and DNA methylation of stress genes,

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2025

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 4, 2025

Completed
21 days until next milestone

First Posted

Study publicly available on registry

February 25, 2025

Completed
1 month until next milestone

Study Start

First participant enrolled

April 1, 2025

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2026

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2026

Completed
Last Updated

February 25, 2025

Status Verified

February 1, 2025

Enrollment Period

12 months

First QC Date

February 4, 2025

Last Update Submit

February 19, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • The main study endpoint is patient comfort measured with the Dutch Version of the COMFORT Behavior (COMFORT-B) scale

    The Comfort B score is used to assess patient comfort. The Comfort-B scale used in this study is a behavioral clinical scale that consists of six factors: alertness, calmness/agitation, respiratory response (or crying, used in patients with no mechanical ventilation), physical movement, muscle tone, and facial tension.(9) Each factor can be scored with values ranging between 1 and 5, generating scores between 6 and 30 points.

    Daily until PICU discharge or up to 28 days, whichever may come first

Secondary Outcomes (12)

  • Parental stress levels

    Within the first 24 hours of PICU admission, and at PICU discharge or at 28 days whichever may come first

  • Quantification of the degree of DNA methylation of stress-related genes.

    Within the first 24 hours of PICU admission, and at PICU discharge or at 28 days whichever may come first

  • Cumulative dose of benzodiazepines, alpha-2-agonists and opioids

    Daily until PICU discharge or up to 28 days, whichever may come first

  • Percentage of asynchronous breaths

    Daily until PICU discharge or up to 28 days, whichever may come first

  • Heart rate

    Daily until PICU discharge or up to 28 days, whichever may come first

  • +7 more secondary outcomes

Study Arms (2)

Live-music therapy

EXPERIMENTAL
Behavioral: Live-music therapy

Care as usual

NO INTERVENTION

Interventions

Children will be offered live-music therapy for 3 consecutive sessions, 30 minute sessions in which 10 to 20 minutes of music is provided by a trained music therapist in the presence of parents. In the sessions, the music therapist will make a tailored plan for each child to avoid overstimulation, which includes choosing the appropriate instrument, determining the child's behavioural state, and continuously monitoring the child (i.e., looking for signs of relaxation but also of overstimulation such as tension, crying movements, hiccups, yawning or frowning). The music therapist will collaborate with parents in constructing a program for the sessions. Parents will be actively involved in the sessions, to stimulate their role as caregiver and empower them. The contents of the live-music is thus constantly evaluated and adapted for the individual child.

Live-music therapy

Eligibility Criteria

Age0 Years - 5 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Children \< 5 years old a

You may not qualify if:

  • CNeurocognitive disorder,
  • Admitted post-operatively with an expected length of stay \<48 hours,
  • Critical situation where end-of-life care is expected
  • Being deaf or suffer from any other hearing impairment, which would not allow for the Music Intervention to be administered
  • Parents are unable to understand / speak Dutch

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Critical Illness

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Central Study Contacts

Martin CJ Kneyber, MD PhD FCCM

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof.dr.

Study Record Dates

First Submitted

February 4, 2025

First Posted

February 25, 2025

Study Start

April 1, 2025

Primary Completion

March 31, 2026

Study Completion

April 30, 2026

Last Updated

February 25, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share